Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EP BiocompositesBOM:543595 +4.72%76 Return-on-Tangible-Equity is 24.10% as of Mar. 2026, which is 86% above its 10-year median of 12.95. GuruFocus rates BOM:543595 with a GF Score™ of 76/100 and a GF Value™ of ₹202.20 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 1,710 Construction companies, EP Biocomposites ranks better than 65.26% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. EP Biocomposites's annualized net income for the quarter that ended in Mar. 2026 was ₹27.4 Mil. EP Biocomposites's average shareholder tangible equity for the quarter that ended in Mar. 2026 was ₹113.5 Mil. Therefore, EP Biocomposites's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 24.10%.
The historical rank and industry rank for EP Biocomposites's Return-on-Tangible-Equity or its related term are showing as below:
BOM:543595'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 10.3 Med: 12.95 Max: 110.53
Current: 13.16
During the past 8 years, EP Biocomposites's highest Return-on-Tangible-Equity was 110.53%. The lowest was 10.30%. And the median was 12.95%.
BOM:543595's Return-on-Tangible-Equity is ranked better than 65.26% of 1710
companies
in the Construction industry
Industry Median: 8.145
vs BOM:543595: 13.16
EP Biocomposites (BOM:543595) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
EP Biocomposites Return-on-Tangible-Equity Related Terms
EP Biocomposites Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for EP Biocomposites's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:543595 vs TT, JCI, CARR: Return-on-Tangible-Equity Comparison
For the Building Products & Equipment subindustry, EP Biocomposites's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EP Biocomposites Return-on-Tangible-Equity vs Construction Industry
For the Construction industry and Industrials sector, EP Biocomposites's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where EP Biocomposites's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 24.10% mean?
EP Biocomposites (BOM:543595) has a Return-on-Tangible-Equity of 24.10% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on EP Biocomposites and its competitors. This is 86% above median its historical median of 12.95. Over the past decade, EP Biocomposites' Return-on-Tangible-Equity has ranged from 10.30 to 110.53. According to the industry distribution chart, EP Biocomposites ranks #594 out of 1710 companies in the Construction industry, placing it in the top 34.7%.
Is EP Biocomposites' Return-on-Tangible-Equity too high?
EP Biocomposites' current Return-on-Tangible-Equity of 24.10% is 86% above median its 10-year median of 12.95. Over the past 10 years, this metric has ranged from a low of 10.30 to a high of 110.53. The Construction industry median Return-on-Tangible-Equity is 8.15. EP Biocomposites' value of 24.10% is 195.9% above this industry median. Based on the distribution chart, EP Biocomposites ranks #594 out of 1710 companies in the Construction industry, which is above the industry midpoint. Overall, EP Biocomposites has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does EP Biocomposites' Return-on-Tangible-Equity compare to TT and JCI?
According to the Construction industry distribution chart, EP Biocomposites ranks #594 out of 1710 companies for Return-on-Tangible-Equity. This puts EP Biocomposites in the upper half of its industry. The industry median Return-on-Tangible-Equity is 8.15. EP Biocomposites' value of 24.10% is 195.9% above this benchmark. Historically, EP Biocomposites' own Return-on-Tangible-Equity has ranged from 10.30 to 110.53 over the past decade. While the company's 10-year median is 12.95 vs. the industry median of 8.15, EP Biocomposites has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Construction company?
The median Return-on-Tangible-Equity among Construction companies is 8.15, based on 1,710 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EP Biocomposites's current Return-on-Tangible-Equity of 24.10% is 195.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on EP Biocomposites and its competitors. For the Construction industry, the median Return-on-Tangible-Equity is 8.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EP Biocomposites's current Return-on-Tangible-Equity is 24.10%, which is 86% above median its own 10-year median of 12.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EP Biocomposites stock overvalued right now?
Based on GuruFocus' analysis, EP Biocomposites (BOM:543595) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹202.20, compared to a current price of ₹111.00 — trading 45.1% below its estimated fair value. The current Return-on-Tangible-Equity is 24.10%, which is 86% above median its 10-year median of 12.95 and 195.9% above the Construction industry median of 8.15. EP Biocomposites' overall GF Score™ is 76/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For EP Biocomposites (BOM:543595), the current Return-on-Tangible-Equity is 24.10% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EP Biocomposites (BOM:543595) Overvalued in 2026?
Based on GuruFocus' analysis, EP Biocomposites stock appears to be undervalued.
The current stock price of ₹111.00 is trading 45.1% below its estimated GF Value™ of ₹202.20.
GuruFocus considers EP Biocomposites to be Significantly Undervalued.
Key valuation signals for BOM:543595:
Return-on-Tangible-Equity: 24.10% (86% above median its 10-year median of 12.95)
GF Value™: ₹202.20 vs. price of ₹111.00 (45.1% below fair value)
Industry Position: 195.9% above the Construction median (#594 of 1710)
No single metric tells the full story. See the BOM:543595 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EP Biocomposites Ltd is the manufacturer and supplier of fibre reinforced polymers products such as door shutters, frames, Biodigestor Tanks, Bio toilets and allied products for construction and Industrial applications. The company focus on giving sanitation solutions to those who do not have access to toilets, as well as to those who have toilets but face trouble treating and managing the waste through septic tanks. The company also provides sanitation infrastructure and human waste management solutions and services, involving simple bio-digester technology licensed from the Defence Research and Development Organisation (DRDO) and Industry Interface and Technology Management, operating under the aegis of DRDO, Ministry of Defence, Government of India.
76GF Score
Get the complete analysis for BOM:543595
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543595 has been successfully added to your 
